MHRA authorises UCB’s bimekizumab through new post-Brexit licensing pathway
The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation for UCB’s Bimzelx®▼(bimekizumab) for the treatment of adults with moderate to severe...
Generic alternative treatment for asthma & COPD available in UK
Lupin Healthcare, the UK-based wholly owned subsidiary of Lupin Limited (Lupin) has announced that following Marketing Authorisation earlier this year, it has launched Luforbec...
Novartis’ Rydapt®▼ receives NICE recommendation
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination recommending Novartis' Rydapt®▼ (midostaurin) for the treatment of aggressive...
Merck partners with start-up for neurostimulator development
Merck has announced a collaboration in its new Bioelectronics innovation field with neuroloop GmbH – a B. Braun subsidiary and early-stage start-up company based...
Avacta appoints Dr Mark Goldberg as Non-Executive Director
Avacta Group, the clinical stage oncology drug company has announced the appointment of Dr Mark Goldberg as Non-executive Director to the Board with immediate...
Weleda partners with Esko to increase pharmaceutical packaging efficiency
Integrated software solutions expert, Esko, has teamed up with Weleda to streamline its pharmaceutical packaging process through the integration of Esko WebCenter with Content Management. Previously, Weleda had used a content management system (CMS) to manage...
Oxford Vaccine Group team begin Phase I trial of new plague vaccine
Researchers at the University of Oxford have launched a Phase 1 trial to test a new vaccine against plague, based on the ChAdOx1 adenovirus...
Almirall’s lebrikizumab shows improvements in Phase III trials
Almirall has announced that two Phase III clinical trials have demonstrated that lebrikizumab, its treatment for moderate-to-severe atopic dermatitis (AD), has shown significant improvements...
Early phase lung drug trial proves hopeful for heart failure patients
An early phase trial, funded by the National Institute for Health Research (NIHR), has shown that a drug currently used to treat lung fibrosis...
LINK Medical appoints Maria Hortlund to strengthen its RWE department
LINK Medical, a contract research organization (CRO) providing product development services for pharmaceutical and medical device industries across Northern Europe, has announced that Maria...
Latest articles
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology
A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
How to digitalise MSL teams for increased efficiency
Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
PM Society Digital Awards Winners 2021
Winners from the 12th PM Society Digital Awards have been announced after the event was held online for the second year in a row,...
New patient coalition launched for digital health technology
A new coalition with members from Royal Colleges, health charities and patient groups has come together to ensure the interests of patients are at the...
Sandoz in commercial agreement with Bio-Thera Solutions for biosimilar bevacizumab
Sandoz, a Novartis division, has strengthened its pipeline by entering into a commercialization agreement with Bio-Thera Solutions, Ltd. for biosimilar bevacizumab (BAT1706) for the...
How to digitalise MSL teams for increased efficiency
Medical Science Liaison (MSL) teams in the pharma industry were already at the limit pre-Covid. Products were complex, wider engagement from healthcare professionals (HCPs)...